is bpc 157 considered natty Peptide Therapy Benefits: BPC-157, TA-1 & GHK-Cu BPC-157 Peptide Therapy for Healing
Description
More recently, a study conducted in human colon carcinoma HCT116 cells showed that lithocholic acid (LCA), a secondary bile acid, stimulates IL-8 expression and induces endothelial cell proliferation and tube like formation in the tumour microenvironment, providing the strong evidence for LCA as a tumour promoter in CRC (126)

In der Literatur wird diese Kombination in Modellen der Sarkopenie (Verlust von Muskelmasse bei Senioren) und der Erholung nach dem Training beschrieben

Jokubaitis, V

Preclinical trials on Survodutide have indicated significant reductions in overall body mass, with particular reductions in visceral fat deposits
Here is the honest evidence status up front, because it shapes everything that follows: the human data on this combination is essentially non-existent